{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "dc3a7ae7-cdd9-4af2-8606-0959e89c3c25", "code": "4789", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4789", "code_system": "IUPHAR", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "3a35d6f9-2624-47f9-8df9-a8f58e1b5d6b", "code": "FLUOROURACIL", "comments": "Description: A white or almost white, crystalline powder. Solubility: Sparingly soluble in water; slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Cytotoxic drug. Storage: Fluorouracil should be kept in a tightly closed container, protected from light. Additional information: Fluorouracil melts at about 282?C with decomposition. CAUTION: Fluorouracil must be handled with care, avoiding contact with the skin and inhalation of airborne particles. Definition: Fluorouracil contains not less than 98.5% and not more than 101.0% of C4H3FN2O2, calculated with reference to the dried substance.", "type": "PRIMARY", "url": "http://apps.who.int/phint/pdf/b/Jb.6.1.183.pdf", "code_system": "WHO INTERNATIONAL PHARMACOPEIA", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "de786185-1e1a-412c-b944-1550cfa1428d", "code": "4492", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/4492/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "0445f63c-0610-46b0-b9ba-e88cf06413c9", "code": "m5483", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m5483?q=authorize", "code_system": "MERCK INDEX", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "eeff129b-6e3e-4e78-9938-fe7aaae8482b", "code": "DB00544", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00544", "code_system": "DRUG BANK", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "5db17ad3-6960-41cd-865b-9c03be70ea0e", "code": "SUB07721MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "52291d8d-fc23-449f-844b-6657da40894e", "code": "CHEMBL185", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185", "code_system": "ChEMBL", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "32c437d0-e13a-481d-bb69-04bcb1446b9b", "code": "200-085-6", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.000.078", "code_system": "ECHA (EC/EINECS)", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "7b3d8e11-6852-4ebb-b904-b903171bd753", "code": "3385", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3385", "code_system": "PUBCHEM", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "aa842a07-e6b7-4db1-92af-bdc0ff9d33d7", "code": "N0000000233", "comments": "Cellular or Molecular Interactions [MoA]|Enzyme Interactions [MoA]|Enzyme Inhibitors [MoA]|Nucleic Acid Synthesis Inhibitors [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000000233", "code_system": "NDF-RT", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "defe3f5d-aeb3-44da-9997-5670753e0629", "code": "N0000175595", "comments": "Established Pharmacologic Class [EPC]|Nucleoside Metabolic Inhibitor [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175595", "code_system": "NDF-RT", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "4f132475-4c11-40c3-93c3-39939340ddef", "code": "L01BC02", "comments": "ATC|ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|ANTINEOPLASTIC AGENTS|ANTIMETABOLITES|Pyrimidine analogues|fluorouracil", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=L01BC02&showdescription=yes", "code_system": "WHO-ATC", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "9c8c7e75-f1c9-4cc8-b127-cfb5fce3aadd", "code": "QL01BC02", "comments": "VATC|ANTINEOPLASTIC AGENTS|ANTIMETABOLITES|Pyrimidine analogues|fluorouracil", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QL01BC02&showdescription=yes", "code_system": "WHO-VATC", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "c9fa5c49-5677-4091-bab9-dc9d620647f6", "code": "QL01BC52", "comments": "VATC|ANTINEOPLASTIC AGENTS|ANTIMETABOLITES|Pyrimidine analogues|fluorouracil, combinations", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QL01BC52&showdescription=yes", "code_system": "WHO-VATC", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "e7128304-0643-4340-b25f-b04ac267f823", "code": "51-21-8", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=51-21-8", "code_system": "CAS", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a", "8ff95a39-65e8-4dba-8f32-6910085b1e40" ] }, { "uuid": "54fce285-8062-4c8c-9616-c990f1d74c6f", "code": "C505", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C505", "code_system": "NCI_THESAURUS", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "3eb49f21-79a0-49c4-a806-cfcd58b2b78d", "code": "D005472", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68005472", "code_system": "MESH", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "273332ec-5ea9-4c94-9e2e-d6c92f4a9e17", "code": "NBK548781", "comments": "LiverTox|Antineoplastic|Solid tumors|Antimetabolite", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548781/", "code_system": "LIVERTOX", "references": [ "e960e4b2-3f1e-bb99-c974-b45412c75fe4" ] }, { "uuid": "26c99c97-6591-4b56-bd0f-50f679e0b463", "code": "FLUOROURACIL", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Fluorouracil", "code_system": "WIKIPEDIA", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "80b58780-24cd-46d8-b098-1b8557a56287", "code": "13.4", "comments": "WHO ESSENTIAL MEDICINES LIST|Dermatological medicines (topical)|Medicines affecting skin differentiation and proliferation", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/178/?section=101#type453", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "576648bc-9ac2-4070-8926-8f4fd6b252b0", "code": "8.2", "comments": "WHO ESSENTIAL MEDICINES LIST|Antineoplastic, immunosuppressives and medicines used in Palliative care|Cytotoxic and adjuvant medicines", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/178/?section=79#type452", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "86fa4497-2544-4b37-9930-a7c4a428e3a6", "code": "L01BC52", "comments": "ATC|ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|ANTINEOPLASTIC AGENTS|ANTIMETABOLITES|Pyrimidine analogues|fluorouracil, combinations", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=L01BC52&showdescription=yes", "code_system": "WHO-ATC", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "ee7c15e8-fe5a-493a-b60f-90238189e7c8", "code": "1421", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=1421", "code_system": "INN", "references": [ "6eadce1d-d389-403f-bbde-36f78711223a" ] }, { "uuid": "d01428f1-1aaa-3e4e-9f20-2f760814a630", "code": "3228", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3228", "code_system": "HSDB", "references": [ "30cb275a-e489-6392-3aa1-01727db394df" ] }, { "uuid": "8a0af836-a566-9d9b-66ef-53cd76b09b67", "code": "DTXSID2020634", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID2020634", "code_system": "EPA CompTox", "references": [ "2e1eae2d-74d4-f850-7f29-26e806660c7c" ] }, { "uuid": "d362497b-a5f8-4fb9-6abf-6c295ef21745", "code": "32088", "comments": "ORPHAN DRUG|Designated/Withdrawn|For use in combination with leucovorin for therapy of metastatic adenocarcinoma of the colon and rectum.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=32088", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "fca02301-03bc-7449-6370-dae563a9ac2e", "code": "131799", "comments": "ORPHAN DRUG|Designated|Treatment of glioblastoma multiforme.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=131799", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "6814bab9-837a-d6f2-c4b3-836e38c4158d", "code": "40589", "comments": "ORPHAN DRUG|Designated|For use in combination with interferon alpha-2a, recombinant, for the treatment of esophageal carcinoma.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=40589", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "8b312c9a-9b3a-e4ac-25b7-dd0f0769bd06", "code": "42289", "comments": "ORPHAN DRUG|Designated|For use in combination with interferon alpha-2a, recombinant, for the treatment of advanced colorectal carcinoma.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=42289", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "40d13ef4-0fd1-7fd4-aa8d-8838bcf82c42", "code": "C1557", "comments": "Pharmacologic Substance[C1909]|Antineoplastic Agent[C274]|Antimetabolite[C272]|Pyrimidine Antagonist", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1557", "code_system": "NCI_THESAURUS", "references": [ "e960e4b2-3f1e-bb99-c974-b45412c75fe4" ] }, { "uuid": "5df28f44-29fb-a79f-c585-da878a5da3a1", "code": "5-Fluorouracil", "comments": "IARC|GROUP 3 ( Not classifiable as to its carcinogenicity to humans)", "type": "PRIMARY", "code_system": "IARC", "references": [ "9d3d3880-c967-7c9a-52fd-66db335c8fa7" ] }, { "uuid": "aef3286f-d14d-27a9-1afd-1ec417632a60", "code": "C2021", "comments": "Pharmacologic Substance[C1909]|Enzyme Inhibitor[C471]|Thymidylate Synthase Inhibitor", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2021", "code_system": "NCI_THESAURUS", "references": [ "e960e4b2-3f1e-bb99-c974-b45412c75fe4" ] }, { "uuid": "d1ff152f-dd2e-f122-fbae-962bf0ff0a06", "code": "EU/3/00/004", "comments": "EU ORPHAN DRUG|Withdrawn|Treatment of glioblastoma", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu300004", "code_system": "EU-Orphan Drug", "references": [ "e960e4b2-3f1e-bb99-c974-b45412c75fe4" ] }, { "uuid": "1e1052c9-6dcf-4e61-9af1-5fdeaaf55319", "code": "U3P01618RT", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "90a642c0-0618-6e48-de94-10fa5db21efe", "code": "1279000", "type": "PRIMARY", "url": "https://store.usp.org/product/1279000", "code_system": "RS_ITEM_NUM", "references": [ "e960e4b2-3f1e-bb99-c974-b45412c75fe4" ] }, { "uuid": "e36f30e6-5eb1-6e7f-9d94-a557110e6c75", "code": "Fluorouracil", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM990/", "code_system": "LACTMED", "references": [ "e960e4b2-3f1e-bb99-c974-b45412c75fe4" ] }, { "uuid": "4fbaa92e-4e22-356d-7c4c-840aaf25cb1b", "code": "26", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/26", "code_system": "DRUG CENTRAL", "references": [ "e960e4b2-3f1e-bb99-c974-b45412c75fe4" ] }, { "uuid": "9b05ae88-41a3-a327-a640-a3ea59313398", "code": "46345", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:46345", "code_system": "CHEBI", "references": [ "e960e4b2-3f1e-bb99-c974-b45412c75fe4" ] }, { "uuid": "e18e6caf-72bb-0fc6-cf87-e60ee2f0cdac", "code": "100000091592", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "d7b90076-d305-8eb5-f3f6-6ce6af5981c5" ] }, { "uuid": "01e50b20-1328-bc08-273a-090c81ceee28", "code": "19893", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=19893", "code_system": "NSC", "references": [ "d5ce599a-3a37-1ff3-9abc-5313ccf5e967" ] }, { "uuid": "cfdc4e2a-1a75-627f-5903-e5ee7368bd7e", "code": "U3P01618RT", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=U3P01618RT", "code_system": "DAILYMED", "references": [ "dba40d29-63ec-7ac4-05f8-6b1e1e8942e5" ] } ], "substance_class": "chemical", "references": [ { "uuid": "e07acbe2-427e-451b-9b63-1206813deb1b", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "56c81167-44f7-4851-a167-01c4793f0de2", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "60497caf-36a1-4482-a411-50e813daa16e", "citation": "USP DICTIONARY", "doc_type": "USP", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f35bc965-3a7d-4fac-bab1-83083a3c058a", "citation": "INN Proposed List 13", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL13.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b8b13c3a-7f34-4449-8b4f-a195ee557c7d", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3a6fda14-f88a-4ff3-948d-506c7b1713ce", "citation": "EP 7.2", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "debb1c58-c632-4ef9-add7-235050f892e2", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2c5e6606-3212-4b57-b863-7869693bba81", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "472394a7-63ac-4038-83cc-2b19ae43f7f5", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "df74dc83-42ca-4d5a-9b8e-b411526787e3", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "965f3ec0-cb40-42fe-aa42-ff72c48f6686", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "6604c770-bda9-4320-8c21-80aea83f2e5d", "citation": "clinicaltrials.gov", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "ef9a7eb7-1947-46ab-84c3-878111989b1e", "citation": "USP/NF", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "33b243c1-3965-420c-b29c-65591ee1c77d", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a9837813-9df9-4b38-8f1c-c3d712cec445", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8f161a32-8f96-473b-adf8-79cc7e50b589", "citation": "EP", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "0ea57c4e-44ea-4638-b498-58aa93d5d316", "citation": "WHO-IP", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "23de93f3-7845-4e66-bd79-4acdf5f1962f", "citation": "SCIFINDER", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c0392bac-5ea1-47c9-974a-af01e3dc2700", "citation": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2709-00b8-4f0a-867c-f0dfeb947192", "url": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2709-00b8-4f0a-867c-f0dfeb947192", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "297eca73-1250-4f2f-b088-3d937d87771e", "citation": "CHEMBL", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "067df7c3-f1ec-4d94-8eea-2ceabe8d732c", "citation": "USP DICTIONARY", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "6eadce1d-d389-403f-bbde-36f78711223a", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389689000, "tags": [ "NOMEN" ] }, { "uuid": "4c605804-237e-49fb-8104-decb373e6d65", "citation": "EP 7.8 FLUOROURACIL MONOGRAPH", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "25648a85-7589-4f1e-ade2-41760f2dbf14", "citation": "USP 35 FLUOROURACIL MONOGRAPH", "doc_type": "USP", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "acbd69ba-a56a-4b51-bb42-f1edbbb216dd", "citation": "THE INTERNATIONAL PHARMACOPOEIA FIFTH EDITION", "url": "http://apps.who.int/phint/en/p/docf/", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "ce838b86-cb35-438d-b23f-c0ca4bb246a9", "citation": "SRS import [U3P01618RT]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=U3P01618RT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389689000, "tags": [ "NOMEN" ] }, { "uuid": "53ea3d37-bb56-4598-bb0b-441922630541", "citation": "FLUOROURACIL [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "1ecd9410-d454-410e-aeab-64b2b10e0164", "citation": "FLUOROURACIL [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "6f802c61-a503-46d9-8214-a97663e79f7a", "citation": "FLUOROURACIL [EP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "4926f6b5-af72-4575-aafd-c84f111eddb2", "citation": "FLUOROURACIL [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "75bb2dbc-4082-4a3b-9536-491118dbc4c6", "citation": "FLUOROURACIL [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "0b0d4c33-d5cc-40d7-bf03-d0188ab51ecc", "citation": "FLUOROURACIL [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "76fcbefe-795f-4d1c-9fd9-3e395ae605ae", "citation": "FLUOROURACIL [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "018a086d-e040-4daf-9aac-9ac30c68a5e9", "citation": "FLUOROURACIL [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "31f470cd-7699-44eb-a8aa-9f57028c6846", "citation": "FLUOROURACIL [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "8e25465b-5fda-4a5d-ab8a-4f2ac0bfaa57", "citation": "FLUOROURACIL [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "bc06c823-59f2-47cc-80df-deb6052d8787", "citation": "FLUOROURACIL [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "33976039-c113-4e93-adf7-9d084ae76173", "citation": "FLUOROURACIL [WHO-IP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "784d55de-8f97-4c47-9d4a-55c15a3ddf0a", "citation": "5-FLUOROURACIL [WHO-IP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "18d40184-0a75-65e8-94df-534e6fb06ef1", "citation": "JAN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "30cb275a-e489-6392-3aa1-01727db394df", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+51-21-8", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2e1eae2d-74d4-f850-7f29-26e806660c7c", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=51-21-8", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "963b80fa-3597-321d-0f09-049825ea2b0b", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+51-21-8", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "554f9387-cfdc-1bce-4661-797a602ae0e7", "citation": "https://en.wikipedia.org/wiki/Thymidylate_synthase", "doc_type": "WIKI", "public_domain": true }, { "uuid": "65773670-b2ed-ff6f-5778-e80679992e15", "citation": "WO2002087586A", "url": "https://encrypted.google.com/patents/WO2002087586A1?cl=en", "doc_type": "PATENT", "public_domain": true }, { "uuid": "e48b5ce6-a02e-fcbf-1e67-206cb46358ec", "citation": "IP", "doc_type": "WHO INTERNATIONAL PHARMACOPOEIA", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "40958e2e-c014-8f5b-2ffc-31af88823132", "citation": "EP", "url": "http://online6.edqm.eu/ep907/", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "9d3d3880-c967-7c9a-52fd-66db335c8fa7", "citation": "IARC", "doc_type": "IARC", "public_domain": true }, { "uuid": "5709d736-b238-6c6d-4ca7-e04695425572", "citation": "USP-NF", "url": "http://app.uspnf.com/uspnf/pub/index?usp=41&nf=36&s=1&officialOn=August%201,%202018", "doc_type": "USPNF", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e960e4b2-3f1e-bb99-c974-b45412c75fe4", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "5447c07b-f6f5-0f12-8256-c133c276769a", "citation": "Longley, Daniel B., D. Paul Harkin, and Patrick G. Johnston. \"5-fluorouracil: mechanisms of action and clinical strategies.\" Nature reviews cancer 3.5 (2003): 330.", "url": "https://www.nature.com/articles/nrc1074", "doc_type": "JA", "public_domain": true }, { "uuid": "8ff95a39-65e8-4dba-8f32-6910085b1e40", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "223e8f1d-648a-15ff-7731-80ffbab7b1fc", "citation": "B-ENT. 2016;12(1):29-32.", "url": "https://www.ncbi.nlm.nih.gov/pubmed/27097391", "doc_type": "JA", "public_domain": true }, { "uuid": "8b16ea1c-c3d8-4835-b4cf-f61c6f3b25f1", "citation": "Peng Li, Guang-Ji Wang, Thomas A. Robertson and Michael S. Roberts, “ Liver Transporters in Hepatic Drug Disposition: An Update”, Current Drug Metabolism (2009) 10: 482.", "url": "https://www.ncbi.nlm.nih.gov/pubmed/19689245", "doc_type": "JA", "public_domain": true }, { "uuid": "7ceb544e-cacc-d8a9-040a-df954077626c", "citation": "USP43-NF38 - 1954, Fluorouracil Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a1294dd3-e0da-3e10-cbe7-e51a504726e5", "citation": "USP 10/2020", "doc_type": "USPNF", "public_domain": true }, { "uuid": "4bdaad24-1a64-45f3-8839-37a47b0c18a9", "citation": "Bocci, Guido, et al. \"Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5, 6-dihydrouracil after conventional and reduced test dose in cancer patients.\" Clinical cancer research 6.8 (2000): 3032-3037.", "url": "https://clincancerres.aacrjournals.org/content/6/8/3032.short", "doc_type": "JA", "public_domain": true }, { "uuid": "c87bb6bf-5d51-d5b2-0f86-70074b734ff7", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "5bb987b1-e3fb-4d43-8d6a-6a6842b59db6", "citation": "folfox", "url": "https://www.cancer.gov/about-cancer/treatment/drugs/folfox", "doc_type": "WEB PAGE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1148a9e5-7bca-4422-a69c-e29c8900d0fd", "citation": "https://go.drugbank.com/drugs/DB00322", "url": "https://go.drugbank.com/drugs/DB00322", "doc_type": "DRUG BANK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "03f4bf9f-33ca-4664-afea-588ff36112a4", "citation": "Peng Li, Guang-Ji Wang, Thomas A. Robertson and Michael S. Roberts, “ Liver Transporters in Hepatic Drug Disposition: An Update”, Current Drug Metabolism (2009) 10: 482.", "url": "https://www.ncbi.nlm.nih.gov/pubmed/19689245", "doc_type": "JA", "public_domain": true }, { "uuid": "d5ce599a-3a37-1ff3-9abc-5313ccf5e967", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "bf79c4fe-b9dc-0324-eb8e-e2031fab8c5e", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "dba40d29-63ec-7ac4-05f8-6b1e1e8942e5", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "d7b90076-d305-8eb5-f3f6-6ce6af5981c5", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "fece959b-412b-4111-a6f7-ed83e5c51e6f", "citation": "WIKIPEDIA FOLFOXIRI", "url": "https://en.wikipedia.org/wiki/FOLFOXIRI", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c4eeac07-2769-4bf3-8b5a-de37dfc4aa6e", "citation": "https://www.cancer.gov/about-cancer/treatment/drugs/FOLFOX", "url": "https://www.cancer.gov/about-cancer/treatment/drugs/FOLFOX", "doc_type": "WEB PAGE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "aab2e9c0-debf-4749-9b3b-9605c048fc8d", "citation": "WIKIPEDIA", "url": "https://en.wikipedia.org/wiki/FOLFOX", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "3860c488-5f78-4152-b300-f20190a6cff3", "id": "3860c488-5f78-4152-b300-f20190a6cff3", "molfile": "\n CDK 02242519482D\n\n 9 9 0 0 0 0 0 0 0 0999 V2000\n 23.3480 -9.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9968 -8.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9968 -6.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 20.6466 -6.1367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 23.3480 -6.1369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 24.6992 -6.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 26.0494 -6.1367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 24.6992 -8.4756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 20.6466 -9.2553 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 2 0 0 0 0\n 2 3 1 0 0 0 0\n 3 4 2 0 0 0 0\n 3 5 1 0 0 0 0\n 5 6 1 0 0 0 0\n 6 7 2 0 0 0 0\n 6 8 1 0 0 0 0\n 1 8 1 0 0 0 0\n 2 9 1 0 0 0 0\nM END", "smiles": "c1c(c(=O)[nH]c(=O)[nH]1)F", "formula": "C4H3FN2O2", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "b16677d6-2884-42e5-9b7d-3996da4b634b" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "130.0774", "optical_activity": "NONE", "stereo_centers": 0 } ], "definition_level": "COMPLETE", "uuid": "4fce1fa0-f8f2-45f5-bcc9-adce7d2850e4", "version": "82", "structure": { "id": "870bcce5-cff3-445e-abc6-e705a22abb8a", "molfile": "\n JSDraw202242519482D\n\n 9 9 0 0 0 0 0 V2000\n 23.3480 -9.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9968 -8.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9968 -6.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 20.6466 -6.1367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 23.3480 -6.1369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 24.6992 -6.9164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 26.0494 -6.1367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 24.6992 -8.4756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 20.6466 -9.2553 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 2 0 0 0 0\n 2 3 1 0 0 0 0\n 3 4 2 0 0 0 0\n 3 5 1 0 0 0 0\n 5 6 1 0 0 0 0\n 6 7 2 0 0 0 0\n 6 8 1 0 0 0 0\n 1 8 1 0 0 0 0\n 2 9 1 0 0 0 0\nM END", "smiles": "c1c(c(=O)[nH]c(=O)[nH]1)F", "formula": "C4H3FN2O2", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "130.0774", "optical_activity": "NONE", "references": [ "ce838b86-cb35-438d-b23f-c0ca4bb246a9", "e07acbe2-427e-451b-9b63-1206813deb1b", "f35bc965-3a7d-4fac-bab1-83083a3c058a" ], "stereo_centers": 0 }, "unii": "U3P01618RT", "relationships": [ { "uuid": "b8c30beb-fbe8-4ef5-95c9-8a88010c3d47", "amount": { "uuid": "17542a7e-64bd-4e20-a5ee-0fea1998adcb" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "d0705077-f449-44c4-bca7-9e5f59a9fa73", "refuuid": "4fce1fa0-f8f2-45f5-bcc9-adce7d2850e4", "name": "Fluorouracil", "unii": "U3P01618RT", "linking_id": "U3P01618RT", "ref_pname": "Fluorouracil", "substance_class": "reference" } }, { "uuid": "f81c4b74-c9ba-4b58-9a41-787e45f1371d", "amount": { "uuid": "35110f4d-d667-4937-a97a-2cdd3b6e291e" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "a116e2b9-05ae-463a-9ce0-11303427b74c", "refuuid": "bfcf87d0-4552-4b74-bd8f-3c3873221b5e", "name": "FLUOROURACIL SODIUM", "unii": "PM476L7O8G", "linking_id": "PM476L7O8G", "ref_pname": "FLUOROURACIL SODIUM", "substance_class": "reference" } }, { "uuid": "dece633d-6741-45de-a229-e7ee7ae45e84", "amount": { "uuid": "6ddd0f1d-c111-4f27-a82e-823460d4bb4b", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 101, "low_limit": 98.5 }, "qualification": "EP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "ASSAY (TITRATION)", "references": [ "4c605804-237e-49fb-8104-decb373e6d65" ], "related_substance": { "uuid": "79b9ab6a-e402-4c99-9be2-49bf87f890bb", "refuuid": "4fce1fa0-f8f2-45f5-bcc9-adce7d2850e4", "name": "Fluorouracil", "unii": "U3P01618RT", "linking_id": "U3P01618RT", "ref_pname": "Fluorouracil", "substance_class": "reference" } }, { "uuid": "b763a3d2-8ef0-400f-8db1-c3889a12aaf0", "amount": { "uuid": "8881d2cf-bd86-4403-ab71-3b00d75925ab", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 102, "low_limit": 98 }, "qualification": "USP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "ASSAY (HPLC)", "references": [ "25648a85-7589-4f1e-ade2-41760f2dbf14" ], "related_substance": { "uuid": "26969732-1cc1-4c37-9f85-9bc0874215e6", "refuuid": "4fce1fa0-f8f2-45f5-bcc9-adce7d2850e4", "name": "Fluorouracil", "unii": "U3P01618RT", "linking_id": "U3P01618RT", "ref_pname": "Fluorouracil", "substance_class": "reference" } }, { "uuid": "34840c23-4633-4474-b0c1-dd2a1b76f003", "amount": { "uuid": "58f1a416-cdf1-42bc-b602-b0dfea77a4c4", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "4c605804-237e-49fb-8104-decb373e6d65" ], "related_substance": { "uuid": "359f2d12-700f-4931-8194-319576f4dcef", "refuuid": "469ce166-e069-432f-bff4-aa2d06638c40", "name": "BARBITURIC ACID", "unii": "WQ92Y2793G", "linking_id": "WQ92Y2793G", "ref_pname": "BARBITURIC ACID", "substance_class": "reference" } }, { "uuid": "2268e857-d2d9-443b-b5a7-c9d24e098518", "amount": { "uuid": "17a3b872-9c42-432d-923a-9cf484cbe43c", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "4c605804-237e-49fb-8104-decb373e6d65" ], "related_substance": { "uuid": "fd42ee94-abf8-43b1-969b-444fbcee597e", "refuuid": "423db876-8ead-4044-b3d9-840dac733944", "name": "ISOBARBITURIC ACID", "unii": "438WJI1S49", "linking_id": "438WJI1S49", "ref_pname": "ISOBARBITURIC ACID", "substance_class": "reference" } }, { "uuid": "c4d9b9e7-114a-431b-bb6e-b04fdaeedde6", "amount": { "uuid": "49c94621-00d4-450e-915f-a192c619a87f", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "4c605804-237e-49fb-8104-decb373e6d65" ], "related_substance": { "uuid": "04e68e9b-15ad-47f9-8899-6e008cc1c0d6", "refuuid": "69e8bfef-e1df-4a3e-8c1e-b68b61b6b28c", "name": "URACIL", "unii": "56HH86ZVCT", "linking_id": "56HH86ZVCT", "ref_pname": "URACIL", "substance_class": "reference" } }, { "uuid": "bde84e0e-3939-4644-88cd-49f945c89366", "amount": { "uuid": "99e257ef-4489-44e5-bdbe-c9de96911a66", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA (CORRECTION FACTOR)", "high_limit": 0.1 }, "comments": "For the calculation of contents, multiply the peak areas by 1.5", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "4c605804-237e-49fb-8104-decb373e6d65" ], "related_substance": { "uuid": "39755b6f-f186-4007-a858-cea52db1b21b", "refuuid": "c99520f0-6714-4aa8-8c65-a62697210881", "name": "5-METHOXYURACIL", "unii": "79DD14XTQR", "linking_id": "79DD14XTQR", "ref_pname": "5-METHOXYURACIL", "substance_class": "reference" } }, { "uuid": "2e355aae-6026-4e7d-a99f-e8f653cebfd8", "amount": { "uuid": "3f8e28bc-9001-4a48-9f6c-f583d5eb56c7", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA (CORRECTION FACTOR)", "high_limit": 0.1 }, "comments": "For the calculation of contents, multiply the peak areas by 1.3", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "4c605804-237e-49fb-8104-decb373e6d65" ], "related_substance": { "uuid": "14099ce0-c7aa-441a-b1d2-dc97745f52ff", "refuuid": "d60b2cb6-f25b-458c-b980-24a38eaba414", "name": "5-CHLOROURACIL", "unii": "7LQ4V03RNY", "linking_id": "7LQ4V03RNY", "ref_pname": "5-CHLOROURACIL", "substance_class": "reference" } }, { "uuid": "51f4d519-e6da-461a-b905-ae496f3f938e", "amount": { "uuid": "421c4387-90be-4586-b24a-383caa059415", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT SPOT INTENSITY", "high_limit": 0.25 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (TLC)", "references": [ "4c605804-237e-49fb-8104-decb373e6d65" ], "related_substance": { "uuid": "0f6d1357-fd15-42dc-a3b9-c9429c057cfb", "refuuid": "a78e5960-068c-4337-b96e-455ba2f12559", "name": "2-ETHOXY-5-FLUOROURACIL", "unii": "15FS54053U", "linking_id": "15FS54053U", "ref_pname": "2-ETHOXY-5-FLUOROURACIL", "substance_class": "reference" } }, { "uuid": "f0957f2a-0323-4907-b84f-135f9aaa13a3", "amount": { "uuid": "87b387b8-ec1b-48ab-80dc-025f028723aa", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT SPOT INTENSITY", "high_limit": 0.2 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (TLC)", "references": [ "4c605804-237e-49fb-8104-decb373e6d65" ], "related_substance": { "uuid": "561270fc-5039-4b39-99f8-ae7a367ef7d6", "refuuid": "565dc0fa-9d15-4b76-b0fb-6a523c991e74", "name": "Urea", "unii": "8W8T17847W", "linking_id": "8W8T17847W", "ref_pname": "Urea", "substance_class": "reference" } }, { "uuid": "e695dda8-3ae4-42b2-b638-4132647469a6", "amount": { "uuid": "1a90b432-736b-49c6-ba82-17c789a87125", "type": "WEIGHT PERCENT", "units": "%", "high_limit": 0.15, "non_numeric_value": "PEAK VALUE" }, "qualification": "EP", "type": "PARENT->IMPURITY", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "e48b5ce6-a02e-fcbf-1e67-206cb46358ec", "40958e2e-c014-8f5b-2ffc-31af88823132" ], "related_substance": { "uuid": "2fc8a180-0565-4913-acd7-e994274481fc", "refuuid": "abff520a-9be3-45ea-9933-1111814c0288", "name": "FLUCYTOSINE", "unii": "D83282DT06", "linking_id": "D83282DT06", "ref_pname": "FLUCYTOSINE", "substance_class": "reference" } }, { "uuid": "504fafb4-85d3-4ff1-b757-1cff19ff9b42", "type": "PARENT->IMPURITY", "references": [ "e48b5ce6-a02e-fcbf-1e67-206cb46358ec", "acbd69ba-a56a-4b51-bb42-f1edbbb216dd" ], "related_substance": { "uuid": "50923874-fb50-4239-a388-0521dc702397", "refuuid": "06babbbe-6fc0-434c-832b-17973c3a52fd", "name": "EMTRICITABINE", "unii": "G70B4ETF4S", "linking_id": "G70B4ETF4S", "ref_pname": "EMTRICITABINE", "substance_class": "reference" } }, { "uuid": "a28cdcc5-9c03-4a72-b613-6f6f8af33016", "type": "PRODRUG->METABOLITE ACTIVE", "related_substance": { "uuid": "7418fc2d-f364-424e-84fd-762faecfc282", "refuuid": "d2a53755-324a-47aa-b042-9ff80c7c5a9f", "name": "CAPECITABINE", "unii": "6804DJ8Z9U", "linking_id": "6804DJ8Z9U", "ref_pname": "CAPECITABINE" } }, { "uuid": "fad25ef3-80b0-4dcc-8535-bbb32b6abbbf", "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "65773670-b2ed-ff6f-5778-e80679992e15" ], "related_substance": { "uuid": "c69a70f4-71f7-41a7-a2b4-c1ca20279277", "refuuid": "341039d4-7d15-4d94-9d2c-e7cb0abf48d1", "name": "TRIAMCINOLONE ACETONIDE 21(5-FLUOROURACIL METHYL FORMATE)", "unii": "F4Q94B6ZNP", "linking_id": "F4Q94B6ZNP", "ref_pname": "TRIAMCINOLONE ACETONIDE 21(5-FLUOROURACIL METHYL FORMATE)", "substance_class": "reference" } }, { "uuid": "5d291722-2753-4f94-b69c-7ff0993dff59", "type": "TARGET->INHIBITOR", "references": [ "554f9387-cfdc-1bce-4661-797a602ae0e7" ], "related_substance": { "uuid": "fae34835-8d87-444f-b109-d8682a5f39b6", "refuuid": "63e3b39e-387c-40e9-94d0-800f6359d565", "name": "THYMIDYLATE SYNTHASE", "unii": "D79B6ADG1E", "linking_id": "D79B6ADG1E", "ref_pname": "THYMIDYLATE SYNTHASE", "substance_class": "reference" } }, { "uuid": "601c199b-6daf-4575-942e-d5979b97b19d", "type": "METABOLITE->PARENT", "related_substance": { "uuid": "6b450a9a-c5aa-4e57-b657-63ee48dda4d4", "refuuid": "109a2e60-3c8a-48b7-bb63-2b7987bcd0c7", "name": ".ALPHA.-FLUOROURIDOPROPIONIC ACID", "unii": "0BXG1I9G0W", "linking_id": "0BXG1I9G0W", "ref_pname": ".ALPHA.-FLUOROURIDOPROPIONIC ACID" } }, { "uuid": "e29a04ee-e49b-443b-9d88-0f614dec3ea3", "type": "METABOLITE INACTIVE->PARENT", "related_substance": { "uuid": "db572d57-e2ec-4736-8f50-2e5450843897", "refuuid": "08654796-cc2b-4c52-a966-f00485efc0be", "name": ".ALPHA.-FLUORO-.BETA.-ALANINE", "unii": "1461S5575Q", "linking_id": "1461S5575Q", "ref_pname": ".ALPHA.-FLUORO-.BETA.-ALANINE" } }, { "uuid": "d2eb3ac2-a7b3-4a8d-a89a-7f6ea8302c0b", "type": "METABOLITE INACTIVE->PARENT", "interaction_type": "MAJOR", "mediator_substance": { "uuid": "3274abe7-8497-4b55-9f3d-a61f9f3b4578", "refuuid": "7879a93d-cf39-4f48-a44e-22c93f1b7e46", "name": "DIHYDROPYRIMIDINE DEHYDROGENASE", "linking_id": "7879a93d-cf39-4f48-a44e-22c93f1b7e46", "ref_pname": "UNSPECIFIED SUBSTANCE", "substance_class": "reference" }, "related_substance": { "uuid": "74e1cdd0-2689-45a6-802a-da07fba319af", "refuuid": "77cb20f7-6e86-492d-bcb9-e6b27b6d7801", "name": "5-FLUORO-5,6-DIHYDROURACIL", "unii": "CLP4LM9HXK", "linking_id": "CLP4LM9HXK", "ref_pname": "5-FLUORO-5,6-DIHYDROURACIL" } }, { "uuid": "7b2b5e74-1ccc-4177-9b3d-8e00651a060f", "type": "METABOLITE ACTIVE->PRODRUG", "references": [ "5447c07b-f6f5-0f12-8256-c133c276769a" ], "related_substance": { "uuid": "a16d1003-ba1f-41f9-bf67-6923e8dda9fc", "refuuid": "7168e3a0-4a76-4d68-94b1-1e23631b9186", "name": "5-FLUOROURIDINE MONOPHOSPHATE", "unii": "BMW6RNK254", "linking_id": "BMW6RNK254", "ref_pname": "5-FLUOROURIDINE MONOPHOSPHATE", "substance_class": "reference" } }, { "uuid": "1db8e2cb-4c33-42df-a60e-f3a092297188", "amount": { "uuid": "a09f80db-6e77-48ba-88a1-c0f8e14545fe" }, "type": "TRANSPORTER->SUBSTRATE", "references": [ "03f4bf9f-33ca-4664-afea-588ff36112a4" ], "related_substance": { "uuid": "49eba573-10d0-48de-8036-5a2b289a6a10", "refuuid": "850b8e0b-d6aa-46e7-8f10-dc0364b1f683", "name": "OAT-2", "unii": "5840721PJZ", "linking_id": "5840721PJZ", "ref_pname": "OAT-2" } }, { "uuid": "ef8491bf-df27-486a-897d-1fc9e7428412", "amount": { "uuid": "e6f6c3c3-356b-4a11-ad17-ed8d46d5c1bb", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "7ceb544e-cacc-d8a9-040a-df954077626c" ], "related_substance": { "uuid": "c64dc154-04b3-4ef7-8124-663cdc05230a", "refuuid": "469ce166-e069-432f-bff4-aa2d06638c40", "name": "BARBITURIC ACID", "unii": "WQ92Y2793G", "linking_id": "WQ92Y2793G", "ref_pname": "BARBITURIC ACID", "substance_class": "reference" } }, { "uuid": "ce168066-8db4-455c-980c-48ae8d850ef0", "amount": { "uuid": "434a2fe5-6292-4133-9c70-e8b4fc8e4c83", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "7ceb544e-cacc-d8a9-040a-df954077626c" ], "related_substance": { "uuid": "97b4d607-f5b3-4e94-8d66-e054423d88ad", "refuuid": "423db876-8ead-4044-b3d9-840dac733944", "name": "ISOBARBITURIC ACID", "unii": "438WJI1S49", "linking_id": "438WJI1S49", "ref_pname": "ISOBARBITURIC ACID", "substance_class": "reference" } }, { "uuid": "04ae619c-bf82-4c52-bbdf-c38534371964", "amount": { "uuid": "e4d49541-32f0-49f2-833a-eb33c8a52583", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "7ceb544e-cacc-d8a9-040a-df954077626c" ], "related_substance": { "uuid": "9b7ec14d-19d2-4fdf-9012-7d02d2029409", "refuuid": "c99520f0-6714-4aa8-8c65-a62697210881", "name": "5-METHOXYURACIL", "unii": "79DD14XTQR", "linking_id": "79DD14XTQR", "ref_pname": "5-METHOXYURACIL", "substance_class": "reference" } }, { "uuid": "7d17c7ce-5308-4f2c-b6c7-c6622a8538af", "amount": { "uuid": "dde1086a-0d08-4b84-a6bb-69299751a095", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "7ceb544e-cacc-d8a9-040a-df954077626c" ], "related_substance": { "uuid": "19b76924-3b3d-4dcf-b829-bf73be050942", "refuuid": "d60b2cb6-f25b-458c-b980-24a38eaba414", "name": "5-CHLOROURACIL", "unii": "7LQ4V03RNY", "linking_id": "7LQ4V03RNY", "ref_pname": "5-CHLOROURACIL", "substance_class": "reference" } }, { "uuid": "d4ed81d8-5ffc-46eb-96d2-70a3a72a457b", "amount": { "uuid": "f31c8ffc-99f5-43d4-9982-3c0ccea97486", "units": "%", "high_limit": 0.25 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (TLC)", "references": [ "7ceb544e-cacc-d8a9-040a-df954077626c" ], "related_substance": { "uuid": "f9ae1581-abeb-4179-9c48-90f53bd207d2", "refuuid": "a78e5960-068c-4337-b96e-455ba2f12559", "name": "2-ETHOXY-5-FLUOROURACIL", "unii": "15FS54053U", "linking_id": "15FS54053U", "ref_pname": "2-ETHOXY-5-FLUOROURACIL", "substance_class": "reference" } }, { "uuid": "0b0f8305-e3f2-4afb-a983-c9ad166f44d3", "amount": { "uuid": "dfc12376-20b0-4569-8752-de2244d96473", "units": "%", "high_limit": 0.2 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (TLC)", "references": [ "7ceb544e-cacc-d8a9-040a-df954077626c" ], "related_substance": { "uuid": "3913e4f6-3799-437b-9b09-edc538085878", "refuuid": "565dc0fa-9d15-4b76-b0fb-6a523c991e74", "name": "Urea", "unii": "8W8T17847W", "linking_id": "8W8T17847W", "ref_pname": "Urea", "substance_class": "reference" } }, { "uuid": "0096ce0d-9087-4230-ae1b-fe540f888375", "amount": { "uuid": "95461543-81e0-4c35-a37d-33b14c7124ac", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "7ceb544e-cacc-d8a9-040a-df954077626c" ], "related_substance": { "uuid": "1e6a65e3-7566-4476-a37e-fa2ccf8833fd", "refuuid": "69e8bfef-e1df-4a3e-8c1e-b68b61b6b28c", "name": "URACIL", "unii": "56HH86ZVCT", "linking_id": "56HH86ZVCT", "ref_pname": "URACIL", "substance_class": "reference" } }, { "uuid": "71f1481f-d40a-43cc-a70e-62679e555d4c", "amount": { "uuid": "5dff0b7b-92a3-42d7-8f15-2f373813e49c" }, "comments": "Down-regulation of ABCB5αresulted in a gain of drug sensitivity to camptothecin 10-OH, 5-fluorouracil, and mitoxantrone.", "type": "TRANSPORTER->SUBSTRATE", "related_substance": { "uuid": "90d2fdfd-32c8-4b6a-b6a1-9dc9c99f28f4", "refuuid": "35397969-c40d-4e7c-949c-29ad58e47ff8", "name": "ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 5", "unii": "GX4RN38YCG", "linking_id": "GX4RN38YCG", "ref_pname": "ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 5" } }, { "uuid": "7aa79bde-46d2-4197-9292-8becfd71a192", "amount": { "uuid": "1bdd8e60-4876-49b9-b8c2-a9d0b422f4b7", "type": "MOLE PERCENT OF AMOUNT ADMINISTERED", "high": 20, "low": 10, "units": "%" }, "type": "EXCRETED UNCHANGED", "references": [ "4bdaad24-1a64-45f3-8839-37a47b0c18a9" ], "related_substance": { "uuid": "ab33a986-9954-47d4-8bab-1d5768563e95", "refuuid": "4fce1fa0-f8f2-45f5-bcc9-adce7d2850e4", "name": "Fluorouracil", "unii": "U3P01618RT", "linking_id": "U3P01618RT", "ref_pname": "Fluorouracil", "substance_class": "reference" } }, { "uuid": "d54b2cbf-cc8e-4954-9134-130bfd0d9bfe", "amount": { "uuid": "a9325297-a7b9-4c26-abd0-c2ee5b1adcaf" }, "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "1148a9e5-7bca-4422-a69c-e29c8900d0fd" ], "related_substance": { "uuid": "69eea6b8-6851-4119-b56a-ddc03542b050", "refuuid": "32e71398-cbb8-4492-ba9b-0b92dd05f89e", "name": "Floxuridine", "unii": "039LU44I5M", "linking_id": "039LU44I5M", "ref_pname": "Floxuridine", "substance_class": "reference" } } ], "names": [ { "uuid": "05e67a27-7ba2-47e2-b935-922473419a48", "name": "2,4(1H,3H)-PYRIMIDINEDIONE, 5-FLUORO-", "stdName": "2,4(1H,3H)-PYRIMIDINEDIONE, 5-FLUORO-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "56c81167-44f7-4851-a167-01c4793f0de2" ], "display_name": false }, { "uuid": "94ad54c2-d33e-4ffd-85ab-4651ef2214b9", "name": "5 FLUOROURACIL", "stdName": "5 FLUOROURACIL", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "6604c770-bda9-4320-8c21-80aea83f2e5d", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "4218549e-639b-49cc-a228-0126434fba16", "name": "5 FU", "stdName": "5 FU", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "6604c770-bda9-4320-8c21-80aea83f2e5d", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "f3cd8e12-acb4-4da0-9fde-d8eceb0c5ae8", "name": "5-FLUORO-URACIL", "stdName": "5-FLUORO-URACIL", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "6604c770-bda9-4320-8c21-80aea83f2e5d", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "33de9bc4-0c61-45b8-a685-0d3e4abdf084", "name": "5-FLUOROPYRIMIDIN-2,4(1H,3H)-DIONE [WHO-IP]", "stdName": "5-FLUOROPYRIMIDIN-2,4(1H,3H)-DIONE [WHO-IP]", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "0ea57c4e-44ea-4638-b498-58aa93d5d316", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "192589b0-47cb-e84a-f647-28224ed6f5d6", "name": "5-FLUOROURACIL [IARC]", "stdName": "5-FLUOROURACIL [IARC]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9d3d3880-c967-7c9a-52fd-66db335c8fa7" ], "display_name": false }, { "uuid": "e8bca5ea-a740-459f-a7a6-fa3d36cfb743", "name": "5-FLUOROURACIL [WHO-IP]", "stdName": "5-FLUOROURACIL [WHO-IP]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "0ea57c4e-44ea-4638-b498-58aa93d5d316", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "3aa34d38-7472-4c00-b936-bb536217f7f6", "name": "5-FLUORURACIL", "stdName": "5-FLUORURACIL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "6604c770-bda9-4320-8c21-80aea83f2e5d", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "0a663bd9-e40a-434e-9801-34f036070eee", "name": "5-FU", "stdName": "5-FU", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "56c81167-44f7-4851-a167-01c4793f0de2", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "802815a7-106b-4c76-ba8f-1d1ac1a5be85", "name": "5-Fluorouracil", "stdName": "5-FLUOROURACIL", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "0ea57c4e-44ea-4638-b498-58aa93d5d316", "56c81167-44f7-4851-a167-01c4793f0de2", "60497caf-36a1-4482-a411-50e813daa16e", "784d55de-8f97-4c47-9d4a-55c15a3ddf0a" ], "display_name": false }, { "uuid": "060beddd-f48d-42f3-88a9-acf5662b7c30", "name": "ADRUCIL", "stdName": "ADRUCIL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "56c81167-44f7-4851-a167-01c4793f0de2", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "471a9a02-27d2-4c3f-851e-3f4d29610ac2", "name": "CARAC", "stdName": "CARAC", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "56c81167-44f7-4851-a167-01c4793f0de2", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "279ca419-50b7-47e9-8dc1-2233e958be06", "name": "EFUDEX", "stdName": "EFUDEX", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "56c81167-44f7-4851-a167-01c4793f0de2", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "209f32c6-27f3-4cd6-919d-23d9e7cb4751", "name": "EMTRICITABINE IMPURITY F [WHO-IP]", "stdName": "EMTRICITABINE IMPURITY F [WHO-IP]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "0ea57c4e-44ea-4638-b498-58aa93d5d316", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "1e503849-224b-28af-f786-b62f8413948c", "name": "FLUCYTOSINE IMPURITY A [EP IMPURITY]", "stdName": "FLUCYTOSINE IMPURITY A [EP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "60497caf-36a1-4482-a411-50e813daa16e", "8f161a32-8f96-473b-adf8-79cc7e50b589", "40958e2e-c014-8f5b-2ffc-31af88823132" ], "display_name": false }, { "uuid": "bacd320b-9667-d181-442e-af836e178874", "name": "FLUCYTOSINE IMPURITY A [WHO-IP]", "stdName": "FLUCYTOSINE IMPURITY A [WHO-IP]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e48b5ce6-a02e-fcbf-1e67-206cb46358ec" ], "display_name": false }, { "uuid": "fecb63f1-fde6-41ab-963c-b11a9a11ac60", "name": "FLUOROPLEX", "stdName": "FLUOROPLEX", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "56c81167-44f7-4851-a167-01c4793f0de2", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "3f1fa51a-dc12-b372-d44d-a526a73d8c01", "name": "FLUOROURACIL [EP MONOGRAPH]", "stdName": "FLUOROURACIL [EP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c87bb6bf-5d51-d5b2-0f86-70074b734ff7" ], "display_name": false }, { "uuid": "d1394673-7643-400a-a195-60e6ab63f339", "name": "FLUOROURACIL [HSDB]", "stdName": "FLUOROURACIL [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "965f3ec0-cb40-42fe-aa42-ff72c48f6686", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "c4045766-a957-413f-ac47-8089340f1b8e", "name": "FLUOROURACIL [JAN]", "stdName": "FLUOROURACIL [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "18d40184-0a75-65e8-94df-534e6fb06ef1" ], "display_name": false }, { "uuid": "eade2934-a2fa-4439-bad3-ba98ed021e91", "name": "FLUOROURACIL [MART.]", "stdName": "FLUOROURACIL [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "472394a7-63ac-4038-83cc-2b19ae43f7f5" ], "display_name": false }, { "uuid": "6ac719e4-e212-4767-86d1-a9fb42371599", "name": "FLUOROURACIL [MI]", "stdName": "FLUOROURACIL [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "df74dc83-42ca-4d5a-9b8e-b411526787e3", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "3d2e0735-f621-4899-86a5-5f0769686723", "name": "FLUOROURACIL [ORANGE BOOK]", "stdName": "FLUOROURACIL [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2c5e6606-3212-4b57-b863-7869693bba81" ], "display_name": false }, { "uuid": "a37bcebe-36fa-4594-85f3-63ca272076a8", "name": "FLUOROURACIL [USAN]", "stdName": "FLUOROURACIL [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b8b13c3a-7f34-4449-8b4f-a195ee557c7d" ], "display_name": false }, { "uuid": "fc0fa93c-2482-8760-23ab-3ebf37cc4729", "name": "FLUOROURACIL [USP MONOGRAPH]", "stdName": "FLUOROURACIL [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a1294dd3-e0da-3e10-cbe7-e51a504726e5" ], "display_name": false }, { "uuid": "771b7e8a-7c23-4d5a-8fb5-b4b18c5bcbf3", "name": "FLUOROURACIL [USP-RS]", "stdName": "FLUOROURACIL [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "ef9a7eb7-1947-46ab-84c3-878111989b1e", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "8cdc31c7-d221-4248-b17e-911690b3968a", "name": "FLUOROURACIL [VANDF]", "stdName": "FLUOROURACIL [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a9837813-9df9-4b38-8f1c-c3d712cec445", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "c3e03cd5-9b4a-44a2-8cc9-5a9fc12b5054", "name": "FLUOROURACIL [WHO-IP]", "stdName": "FLUOROURACIL [WHO-IP]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "0ea57c4e-44ea-4638-b498-58aa93d5d316", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "0a59bdb0-4e48-45ac-b337-9891076a23b4", "name": "FLUOROURACILUM [WHO-IP LATIN]", "stdName": "FLUOROURACILUM [WHO-IP LATIN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "0ea57c4e-44ea-4638-b498-58aa93d5d316", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "61d6f92a-86b6-a9fe-f290-fd8c3ccd8341", "name": "FLUOROURICIL", "stdName": "FLUOROURICIL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "223e8f1d-648a-15ff-7731-80ffbab7b1fc" ], "display_name": false }, { "uuid": "4fb2dad7-b9b7-4e3b-be05-263246b08573", "name": "Fluorouracil", "stdName": "FLUOROURACIL", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "33b243c1-3965-420c-b29c-65591ee1c77d", "3a6fda14-f88a-4ff3-948d-506c7b1713ce", "b8b13c3a-7f34-4449-8b4f-a195ee557c7d", "1ecd9410-d454-410e-aeab-64b2b10e0164", "75bb2dbc-4082-4a3b-9536-491118dbc4c6", "f35bc965-3a7d-4fac-bab1-83083a3c058a", "472394a7-63ac-4038-83cc-2b19ae43f7f5", "ef9a7eb7-1947-46ab-84c3-878111989b1e", "a9837813-9df9-4b38-8f1c-c3d712cec445", "0b0d4c33-d5cc-40d7-bf03-d0188ab51ecc", "31f470cd-7699-44eb-a8aa-9f57028c6846", "8e25465b-5fda-4a5d-ab8a-4f2ac0bfaa57", "bc06c823-59f2-47cc-80df-deb6052d8787", "debb1c58-c632-4ef9-add7-235050f892e2", "e07acbe2-427e-451b-9b63-1206813deb1b", "76fcbefe-795f-4d1c-9fd9-3e395ae605ae", "4926f6b5-af72-4575-aafd-c84f111eddb2", "df74dc83-42ca-4d5a-9b8e-b411526787e3", "53ea3d37-bb56-4598-bb0b-441922630541", "0ea57c4e-44ea-4638-b498-58aa93d5d316", "965f3ec0-cb40-42fe-aa42-ff72c48f6686", "2c5e6606-3212-4b57-b863-7869693bba81", "018a086d-e040-4daf-9aac-9ac30c68a5e9", "60497caf-36a1-4482-a411-50e813daa16e", "33976039-c113-4e93-adf7-9d084ae76173", "6f802c61-a503-46d9-8214-a97663e79f7a" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "a5f227f1-32ce-4d13-99f9-37d8f31dcbab", "name_org": "INN" }, { "uuid": "46b2fcd7-0041-433b-84cf-0cf022aca744", "name_org": "USAN" } ] }, { "uuid": "24ca73b1-64a8-fccb-4f30-676de5181fe4", "name": "Fluorouracil [WHO-DD]", "stdName": "FLUOROURACIL [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "bf79c4fe-b9dc-0324-eb8e-e2031fab8c5e" ], "display_name": false }, { "uuid": "8a1a4d9c-ac5d-4a6d-b99f-f98bf0a969ad", "name": "Folfox component fluorouracil", "stdName": "FOLFOX COMPONENT FLUOROURACIL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5bb987b1-e3fb-4d43-8d6a-6a6842b59db6" ], "display_name": false }, { "uuid": "ca995ba4-9b8b-46ed-a079-182ef4d3306f", "name": "NSC-19893", "stdName": "NSC-19893", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "56c81167-44f7-4851-a167-01c4793f0de2", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "0c527c56-962c-44b7-91af-e957083f8a61", "name": "PHTHORURACIL", "stdName": "PHTHORURACIL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "23de93f3-7845-4e66-bd79-4acdf5f1962f", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "2185d5fa-fcef-43ea-8380-fdbbc1728836", "name": "QUEROPLEX", "stdName": "QUEROPLEX", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "23de93f3-7845-4e66-bd79-4acdf5f1962f", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "cdf41a75-6c77-4d37-9d4f-8d0c22320999", "name": "RO 2-9757", "stdName": "RO 2-9757", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "56c81167-44f7-4851-a167-01c4793f0de2", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "73886ad1-f969-43ac-824b-14acc141957b", "name": "RO-2-9757", "stdName": "RO-2-9757", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "067df7c3-f1ec-4d94-8eea-2ceabe8d732c", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "5dcfa531-e8bb-4d38-821a-0a304be64d00", "name": "RO-29757", "stdName": "RO-29757", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "297eca73-1250-4f2f-b088-3d937d87771e", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "4a3f2112-2098-471c-9842-13cda0183e6c", "name": "TOLAK", "stdName": "TOLAK", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "c0392bac-5ea1-47c9-974a-af01e3dc2700", "60497caf-36a1-4482-a411-50e813daa16e" ], "display_name": false }, { "uuid": "fd4ee90d-197f-4bad-a250-3fdf832cb324", "name": "fluorouracil [INN]", "stdName": "FLUOROURACIL [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f35bc965-3a7d-4fac-bab1-83083a3c058a" ], "display_name": false } ], "modifications": { "uuid": "b55e3b73-b741-4146-a78a-95c3f7dfbe61" } } ] }